About
About
Close
About Circio
Pipeline
Management Team
Board of Directors
Careers
circRNA
circRNA
Close
Circio AB
circVec platform
Clinical programs
Clinical programs
Close
ONCOS-102
KRAS program
Publications
Partnering
Investors
Investors
Close
Press releases
Events
Financial Reports
Presentations
Prospectus
Debt
Share information
Share facts
Largest shareholders
Dividend policy
Analyst coverage
Registrar and auditor
Corporate Governance Policy
Corporate Social Responsibility Principles
Remuneration Principles
About General Meeting
General Meetings
Board of Directors
Nomination Committee
Committees
Management
Articles of Association
Contact
Media
Media
Close
Press releases
Events
Subscribe
Contact
Contacts
Contacts
Close
Offices
Investors & Media
About
About Circio
Our pipeline
Management Team
Board of Directors
Collaborations
Careers
circRNA
Circio AB
circVec platform
Clinical programs
ONCOS-102
KRAS program
Publications
Partnering
Partnering
Investors
Press releases
Events
Financial Reports
Presentations
Prospectus
Debt
Share information
Share facts
Largest shareholders
Dividend policy
Analyst coverage
Registrar and auditor
Corporate Governance Policy
Corporate Social Responsibility Principles
Remuneration Principles
About General Meeting
General Meetings
Board of Directors
Nomination Committee
Committees
Management
Articles of Association
Contact
Subscribe
Contact
Media
Press releases
Events
Subscribe
Contact
Contacts
Offices
Investors & Media
Search for:
Building next generation RNA
therapeutics
News
May 31, 2023
Circio invites to a company update on Thursday 15 June 2023
May 26, 2023
Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds
May 25, 2023
Circio Holding ASA – New name registered
All news
Events
June 2 - June 6, 2023
American Society of Clinical Oncology (ASCO)
Chicago
Add to Calendar
June 5 - June 8, 2023
BIO International Convention
Boston
Add to Calendar
All events
Company presentation
Company presentation April
Share price
Subscribe
Press releases
Financial reports
Read more about our Protection of your personal data.